AI assistant
Moderna, Inc. — Director's Dealing 2025
Feb 28, 2025
30610_dirs_2025-02-28_081960b0-5745-4d8d-bd71-a3f828fa9ec7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2025-02-27
Reporting Person: Klinger Shannon Thyme (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-27 | Common Stock | M | 3094 | — | Acquired | 24861 | Direct |
| 2025-02-27 | Common Stock | F | 1496 | $33.58 | Disposed | 23365 | Direct |
| 2025-02-27 | Common Stock | M | 2653 | — | Acquired | 26018 | Direct |
| 2025-02-27 | Common Stock | F | 1283 | $33.58 | Disposed | 24735 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-27 | Restricted Stock Units | $ | M | 3094 | Disposed | Common Stock (3094) | Direct | |
| 2025-02-27 | Restricted Stock Units | $ | M | 2653 | Disposed | Common Stock (2653) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Includes 342 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on December 13, 2024.
F3: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F4: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F5: 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.